H20020252 | 甲氨蝶吟注射液 | methotrexate | Injection | Chemical Drugs | Import Drug Application | 2002-10-24 | 香港凯健药品(中国)有限公司北京代表处 | | Approval Completed-Pending Certificated | 2003-08-15 | view |
JYHB1601448 | 甲氨蝶呤注射液 | methotrexate | Injection | Chemical Drugs | Supplementary Application | 2016-10-31 | 辉瑞投资有限公司 | Pfizer Investment Co Ltd | Certificate Issued | 2017-04-13 | view |
JYHZ1800250 | 甲氨蝶呤注射液 | methotrexate | Injection | Chemical Drugs | License Renew | 2018-08-22 | 辉瑞投资有限公司 | Pfizer Investment Co Ltd | Certificate Issued | 2019-03-21 | view |
JYHB1400265 | 甲氨蝶呤注射液 | methotrexate | Injection | Chemical Drugs | Supplementary Application | 2014-04-09 | 辉瑞投资有限公司 | Pfizer Investment Co Ltd | Certificate Issued | 2015-04-07 | view |
JYHB1501246 | 甲氨蝶呤注射液 | methotrexate | Injection | Chemical Drugs | Supplementary Application | 2015-09-09 | 辉瑞投资有限公司 | Pfizer Investment Co Ltd | Certificate Issued | 2016-07-29 | view |
JYHB1700168 | 甲氨蝶呤注射液 | methotrexate | Injection | Chemical Drugs | Supplementary Application | 2017-02-20 | 辉瑞投资有限公司 | Pfizer Investment Co Ltd | Certificate Issued | 2017-06-12 | view |
JYHB1800054 | 甲氨蝶呤注射液 | methotrexate | Injection | Chemical Drugs | Supplementary Application | 2018-02-02 | 辉瑞投资有限公司 | Pfizer Investment Co Ltd | Certificate Issued | 2018-05-02 | view |
JYHB1400267 | 甲氨蝶呤注射液 | methotrexate | Injection | Chemical Drugs | Supplementary Application | 2014-04-09 | 辉瑞投资有限公司 | Pfizer Investment Co Ltd | Certificate Issued | 2015-04-07 | view |
JYHB1700170 | 甲氨蝶呤注射液 | methotrexate | Injection | Chemical Drugs | Supplementary Application | 2017-02-20 | 辉瑞投资有限公司 | Pfizer Investment Co Ltd | Certificate Issued | 2017-06-12 | view |
JYHB1601447 | 甲氨蝶呤注射液 | methotrexate | Injection | Chemical Drugs | Supplementary Application | 2016-10-31 | 辉瑞投资有限公司 | Pfizer Investment Co Ltd | Certificate Issued | 2017-04-13 | view |
JYHB1700169 | 甲氨蝶呤注射液 | methotrexate | Injection | Chemical Drugs | Supplementary Application | 2017-02-20 | 辉瑞投资有限公司 | Pfizer Investment Co Ltd | Certificate Issued | 2017-06-12 | view |
JYHZ1800252 | 甲氨蝶呤注射液 | methotrexate | Injection | Chemical Drugs | License Renew | 2018-08-22 | 辉瑞投资有限公司 | Pfizer Investment Co Ltd | Certificate Issued | 2019-03-21 | view |
JYHB1501245 | 甲氨蝶呤注射液 | methotrexate | Injection | Chemical Drugs | Supplementary Application | 2015-09-09 | 辉瑞投资有限公司 | Pfizer Investment Co Ltd | Certificate Issued | 2016-07-29 | view |
JYHB1800053 | 甲氨蝶呤注射液 | methotrexate | Injection | Chemical Drugs | Supplementary Application | 2018-02-02 | 辉瑞投资有限公司 | Pfizer Investment Co Ltd | Certificate Issued | 2018-05-02 | view |
JYHB1400266 | 甲氨蝶呤注射液 | methotrexate | Injection | Chemical Drugs | Supplementary Application | 2014-04-09 | 辉瑞投资有限公司 | Pfizer Investment Co Ltd | Certificate Issued | 2015-04-07 | view |
JYHB1601446 | 甲氨蝶呤注射液 | methotrexate | Injection | Chemical Drugs | Supplementary Application | 2016-10-31 | 辉瑞投资有限公司 | Pfizer Investment Co Ltd | Certificate Issued | 2017-04-13 | view |
JYHZ1800251 | 甲氨蝶呤注射液 | methotrexate | Injection | Chemical Drugs | License Renew | 2018-08-22 | 辉瑞投资有限公司 | Pfizer Investment Co Ltd | Certificate Issued | 2019-03-21 | view |
JYHB1501247 | 甲氨蝶呤注射液 | methotrexate | Injection | Chemical Drugs | Supplementary Application | 2015-09-09 | 辉瑞投资有限公司 | Pfizer Investment Co Ltd | Certificate Issued | 2016-07-29 | view |
JYHB1800052 | 甲氨蝶呤注射液 | methotrexate | Injection | Chemical Drugs | Supplementary Application | 2018-02-02 | 辉瑞投资有限公司 | Pfizer Investment Co Ltd | Certificate Issued | 2018-05-02 | view |
JYHB1400269 | 甲氨蝶呤注射液 | methotrexate | Injection | Chemical Drugs | Supplementary Application | 2014-03-08 | 赫升瑞(中国)企业管理有限公司 | HOSPIRA(China)ENTERPRISE Management Co Ltd | Certificate Issued | 2016-03-11 | view |